share_log

McDonald's | PX14A6G: Notice of exempt solicitation

McDonald's | PX14A6G: Notice of exempt solicitation

麥當勞 | PX14A6G:豁免招標通知
美股SEC公告 ·  04/19 02:27

Moomoo AI 已提取核心訊息

The Shareholder Commons, Inc. has submitted a proposal urging shareholders to vote in favor of Item 6 at the upcoming McDonald's Corporation Annual Meeting on May 22, 2024. The proposal calls for McDonald's to adopt an enterprise-wide policy to phase out the use of medically-important antibiotics for disease prevention in its beef and pork supply chains. This initiative aligns with WHO guidelines and aims to mitigate the risks posed by antimicrobial resistance (AMR) to public health and the economy. McDonald's, being the largest beef purchaser in the U.S. and a major pork buyer, has significant influence on market practices. The company opposes the proposal, claiming it is unnecessary, duplicative, and would not benefit shareholders. However, The Shareholder...Show More
The Shareholder Commons, Inc. has submitted a proposal urging shareholders to vote in favor of Item 6 at the upcoming McDonald's Corporation Annual Meeting on May 22, 2024. The proposal calls for McDonald's to adopt an enterprise-wide policy to phase out the use of medically-important antibiotics for disease prevention in its beef and pork supply chains. This initiative aligns with WHO guidelines and aims to mitigate the risks posed by antimicrobial resistance (AMR) to public health and the economy. McDonald's, being the largest beef purchaser in the U.S. and a major pork buyer, has significant influence on market practices. The company opposes the proposal, claiming it is unnecessary, duplicative, and would not benefit shareholders. However, The Shareholder Commons refutes these claims, highlighting the systemic threat of AMR, which could cost the global economy $100 trillion by 2050. They argue that McDonald's current policies do not sufficiently address the risks and that the company has failed to meet its own antibiotic use reduction commitments. The Shareholder Commons emphasizes the importance of considering the broader economic impact and the health of diversified investment portfolios, rather than focusing solely on McDonald's financial performance.
股東下議院已提交一份提案,敦促股東在即將於2024年5月22日舉行的麥當勞公司年會上對第6項投贊成票。該提案要求麥當勞採取一項全企業政策,逐步停止在其牛肉和豬肉供應鏈中使用具有重要醫學意義的抗生素來預防疾病。該舉措符合世衛組織的指導方針,旨在減輕抗微生物藥物耐藥性(AMR)對公共衛生和經濟構成的風險。麥當勞是美國最大的牛肉購買者和主要的豬肉買家,對市場慣例具有重大影響。該公司反對該提案,聲稱該提案沒有必要,是重複的,不會使股東受益。但是,股東下議院駁斥了這些說法,強調了抗微生物藥物耐藥性的系統性威脅,到2050年,抗微生物藥物耐藥性可能使全球經濟損失100萬億美元。他們認爲,麥當勞目前的政策不足以應對風險,而且該公司未能兌現自己的減少抗生素使用的承諾。股東下議院強調必須考慮更廣泛的經濟影響和多元化投資組合的健康狀況,而不是隻關注麥當勞的財務業績。
股東下議院已提交一份提案,敦促股東在即將於2024年5月22日舉行的麥當勞公司年會上對第6項投贊成票。該提案要求麥當勞採取一項全企業政策,逐步停止在其牛肉和豬肉供應鏈中使用具有重要醫學意義的抗生素來預防疾病。該舉措符合世衛組織的指導方針,旨在減輕抗微生物藥物耐藥性(AMR)對公共衛生和經濟構成的風險。麥當勞是美國最大的牛肉購買者和主要的豬肉買家,對市場慣例具有重大影響。該公司反對該提案,聲稱該提案沒有必要,是重複的,不會使股東受益。但是,股東下議院駁斥了這些說法,強調了抗微生物藥物耐藥性的系統性威脅,到2050年,抗微生物藥物耐藥性可能使全球經濟損失100萬億美元。他們認爲,麥當勞目前的政策不足以應對風險,而且該公司未能兌現自己的減少抗生素使用的承諾。股東下議院強調必須考慮更廣泛的經濟影響和多元化投資組合的健康狀況,而不是隻關注麥當勞的財務業績。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息